Watts Schizo Flashcards

1
Q

Etiology of schizophrenia

A

-Neurodevelopmental/anatomical
-Genetics-neuronal growth, migration of neurons
-Environmental-birth complications, infections
-Gene-environment interaction
-Neurodevelopment-environment interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are positive symptoms of schizophrenia?

A

-Respond well to drug therapy
-Hallucinations
-Delusions
-Bizarre behavior
-Thought disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are negative symptoms of schizophrenia?

A

-Little response to drug therapy, newer agents are better
-Blunted emotion
-Poor self-care
-Social withdrawal
-Poverty in speech

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the receptors antagonized by antipsychotics?

A

-Dopamine
-Serotonin
-Norepinephrine
-Acetylcholine
-Histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the major receptor antagonized by antipsychotics?

A

Dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the newer receptor antagonized by antipsychotics?

A

Serotonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What has more predictable dosing, D2 or D1?

A

D2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Actions of D2 antagonists on the basal ganglia (nigrostriatal pathway)

A

-Motor effects
-Extrapyramidal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Actions of D2 antagonists on the mesolimbic

A

Primary therapeutic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Actions of D2 antagonists on the mesocortical

A

-Hypofunction in schizophrenia
-Antagonists may exacerbate cognitive deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Actions of D2 antagonists on the Hypothalamus and endocrine systems

A

D2 receptor blockade in endocrine system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Actions of D2 antagonists on the medulla

A

-Chemoreceptor trigger zone
-D2 antagonists are anti-emetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drug-induced movement disorders (D2 antagonism)

A

-Extrapyramidal symptoms (EPS) (30-50%)
-Tardive dyskinesia (20-40%)
-Neuroleptic malignant syndrome (NMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When do extrapyramidal symptoms appear?

A

Occur early, days/weeks, reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the extrapyramidal symptoms?

A

-Dystonia - increased muscle tone
-Pseudoparkinsonism - muscle rigidity
-Tremor
-Akathisia - restlessness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug therapy for EPS

A

-Anticholinergic agents
-Antihistamines
-Dopamine-releasing agents
-Used for akathisia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When does tardive dyskinesia appear

A

Occur late, months to a year, IRREVERSIBLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Symptoms of tardive dyskinesia

A

-Mouth - rhythmic involuntary movements
-Choreiform - irregular purposelessness
-Athetoid - worm-like
-Axial hyperkinesias - “to-and-fro” movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Monitoring of tardive dyskinesia

A

AIMS (abnormal involuntary movement scale) rating scale; check every 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Treatment of tardive dyskinesia

A

-Prevention! Use the least risky agent at the lowest dose possible and monitor
-Reduce dose of current agent
-Change to a different drug; possibly a newer agent
-Eliminate anticholinergic drugs
-VMAT inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the VMAT inhibitors for tardive dyskinesia

A

-Tetrabenazine (Xenazine) for Huntington’s chorea
-Valbenazine (Ingrezza) for TD
-Deutetrabenazine (Austedo) for TD and Huntington’s chorea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When does neuroleptic malignant syndrome appear?

A

Immediately and serious; 10% fatality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the symptoms of neuroleptic malignant syndrome?

A

-EPS symptoms with fever
-Impaired cognition - agitation, delirium, coma
-Muscle rigidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Treatment of neuroleptic malignant syndrome

A

-Restore dopamine balance
-Discontinue drug
-DA agonists, diazepam, or dantrolene (skeletal muscle relaxant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How long does it take for antipsychotic drugs to take effect when treating psychosis?
-2-3 weeks for effectiveness -6 weeks to 6 months maximal efficacy
26
Pharmacological effects of the antipsychotic drugs
-Behavioral effects: Unpleasant in normal subjects or reversal of signs and symptoms of psychosis in affected individual -"Neuroleptic" syndrome: Suppress emotions, reduce initiative and interest, affect; may resemble negative symptoms -Block conditioned avoidance responses in animal studies -Decreased spontaneous activity, aggressive, and impulsive behavior
27
Manifestations associated with muscarinic cholinoreceptor blockade
-Loss of accommodation -Dry mouth -Difficulty urinating -Constipation
28
Manifestations associated with alpha adrenoreceptor blockade
-Orthostatic hypotension -Impotence -Failure to ejaculate
29
Manifestations associated with dopamine receptor blockade
-Parkinson's syndrome -Akathisia -Dystonias
30
Manifestations associated with supersensitivity of dopamine receptors
Tardive dyskinesia
31
Manifestations associated with muscarinic blockade
Toxic-confusional state
32
Manifestations associated with histamine receptor blockade
Sedation
33
Manifestations associated with dopamine receptor blockade resulting in hyperprolactinemia
-Amenorrhea-galactorrhea -Infertility -Impotence
34
Manifestations associated with combined histamine and serotonin blockade
Weight gain
35
Precautions/contraindications associated with antipsychotic drugs
-Cardiovascular (hypotension and QT interval prolongation) -Parkinsons disease -Epilepsy (clozapine will lower seizure threshold) -Diabetes (contraindicated for newer agents)
36
What does a drug that has high serotonin/dopamine ratio cause?
EPS
37
What are the aliphatic phenothiazines?
-Chlorpromazine (Thorazine) - no longer first-line therapy -Promethazine (Phenergan) - more likely to be used for N/V
38
Which aliphatic phenothiazine is more likely to be used for H1 antagonist properties?
Promethazine
39
What are the piperidine phenothiazines?
Thioridazine (Mellaril) - sedation, hypotension; anticholinergic, many SE
40
What are the piperazine phenothiazines?
-Fluphenazine (Permtil, Prolixin) - EPS -Prochlorperazine (Compazine) - antiemetic -Perphenazine (Trilafon) - just as effective as newer agents
41
What are the thioxanthines?
-Thiothizene (Navane) - modest EPS
42
What are the butyrophenones?
-Haloperidol (Haldol) - EPS
43
Miscellaneous antipsychotics
-Molindone (Moban) - moderate EPS -Pimozide (Orap) - Tourette's disease-tics, vocalizations
44
Key points of chlorpromazine (Thorazine)
-First antipsychotic -Antihistamine side effects
45
Key points of promethazine (Phenergan)
-Antihistamine -Antiemetic
46
Key points of thioridazine (Mellaril)
-Many side effects: anticholinergic, sexual dysfunction, cardiovascular
47
Key points of perphenazine (Trilafon)
CATIE studies: combination with anticholinergic
48
Key points of thiothixene (Navane)
Modest EPS
49
Key points of haloperidol (Haldol)
EPS
50
Key points of molindone (Moban)
Moderate EPS
51
Key points of pimozide (Orap)
Tourette's disease, suppress motor and vocal tics
52
Atypical/second generation antipsychotics
-Clozapine -Olanzapine -Loxapine -Quetiapine -Risperidone -Paliperidone -Iloperidone -Ziprasidone -Asenapine -Lurasidone -Pimavanserin -Aripiprazole
53
D2/D3 partial agonists
-Brexpiprazole -Cariprazine -Lumateperone
54
Clozapine key points
-First atypical antipsychotic -Agranulocytosis -Risk of diabetes -Superior efficacy
55
Olanzapine key points
-Weight gain -Risk of diabetes
56
Quetiapine key points
-Metabolite with antidepressant activity -Hypotension -Sedation
57
Risperidone key points
-Serotonin/dopamine receptor antagonist
58
Ziprasidone key points
-Serotonin/dopamine, alpha 1 affinity -prolongs QT interval
59
Lurasidone key points
-Serotonin/dopamine receptor affinity -Reduced metabolic effects -Rapid titration
60
Aripiprazole key points
-High serotonin/dopamine receptor affinity -Partial agonist activity
61
Drugs in development/under investigation
Dual M1/M4 muscarinic agonist combined with peripheral muscarinic antagonist (KarXT)